Shares of AbbVie rose 2.87% to $112.93 at 14:00 EST on Wednesday, after four sequential sessions in a row of gains. NYSE Composite is dropping 0.03% to $15,006.06, following last session’s upward trend, This seems, as yet, a somewhat negative trend exchanging session today.
AbbVie’s last close was $109.78, 0.04% below its 52-week high of $112.89.
AbbVie’s sales growth is 57.7% for the ongoing quarter and 50.4% for the next. The company’s growth estimates for the current quarter and the next is 29.4% and 18.2%, respectively.
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
AbbVie’s last day, last week, and last month’s average volatility was 0.70%, 0.61%, and 0.10%, respectively.
AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 1.52%, 1.96%, and 2.01%, respectively.
AbbVie’s Stock Yearly Top and Bottom Value
AbbVie’s stock is valued at $112.93 at 14:00 EST, above its 52-week high of $112.89.
AbbVie’s Moving Average
AbbVie’s value is above its 50-day moving average of $105.44 and way above its 200-day moving average of $95.77.